Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 137304, 10 pages
http://dx.doi.org/10.1155/2014/137304
Research Article

Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry

1Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany
2Center for Clinical Studies, University Hospital Regensburg, 93053 Regensburg, Germany
3Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany
4Tumor Center Regensburg e.V., University of Regensburg, 93053 Regensburg, Germany

Received 10 January 2014; Accepted 6 February 2014; Published 20 March 2014

Academic Editor: Peter A. Fasching

Copyright © 2014 E. C. Inwald et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • E. C. Inwald, M. Klinkhammer-Schalke, M. Koller, and O. Ortmann, “Quality Assurance for Patients with Breast Cancer - the Impact of Clinical Cancer Registries,” Geburtshilfe und Frauenheilkunde, vol. 74, no. 9, pp. 868–874, 2014. View at Publisher · View at Google Scholar
  • Patrizia Vici, Laura Pizzuti, Clara Natoli, Luca Moscetti, Lucia Mentuccia, Angela Vaccaro, Domenico Sergi, Luigi Di Lauro, Patrizia Trenta, Patrizia Seminara, Daniele Santini, Laura Iezzi, Nicola Tinari, Ilaria Bertolini, Valentina Sini, Marcella Mottolese, Diana Giannarelli, Francesco Giotta, Marcello Maugeri-Sacca, Maddalena Barba, Paolo Marchetti, Andrea Michelotti, Isabella Sperduti, and Teresa Gamucci, “Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study,” Breast Cancer Research and Treatment, vol. 147, no. 3, pp. 599–607, 2014. View at Publisher · View at Google Scholar
  • Monika Nothacker, Cathleen Muche-Borowski, and Ina B. Kopp, “Reflections on 20 years of clinical practice guideline programmes in Germany: What is their impact?,” Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, vol. 108, no. 10, pp. 550–559, 2014. View at Publisher · View at Google Scholar
  • Elisabeth Christine Inwald, M. Koller, M. Klinkhammer-Schalke, F. Zeman, F. Hofstädter, M. Gerstenhauer, G. Brockhoff, and O. Ortmann, “4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival,” Breast Cancer Research and Treatment, 2015. View at Publisher · View at Google Scholar
  • E. C. Inwald, M. Koller, M. Klinkhammer-Schalke, F. Zeman, F. Hofstädter, P. Lindberg, M. Gerstenhauer, S. Schüler, O. Treeck, and O. Ortmann, “Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry,” Journal of Cancer Research and Clinical Oncology, 2015. View at Publisher · View at Google Scholar
  • S. Subramaniam, N. Bhoo-Pathy, N. A. Taib, G. H. Tan, M. H. See, S. Jamaris, G. F. Ho, L. M. Looi, and C. H. Yip, “Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country,” World Journal of Surgery, 2015. View at Publisher · View at Google Scholar
  • Hartmut Link, J. Nietsch, M. Kerkmann, and P. Ortner, “Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy—a representative sample survey in Germany,” Supportive Care in Cancer, 2015. View at Publisher · View at Google Scholar
  • Anne-Sophie Hamy-Petit, Lisa Belin, Hélène Bonsang-Kitzis, Caroline Paquet, Jean-Yves Pierga, Florence Lerebours, Paul Cottu, Roman Rouzier, Alexia Savignoni, Marick Lae, and Fabien Reyal, “Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort,” British Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Jean-Baptiste Delhorme, Delphine Antoni, Kimberley S. Mak, Francois Severac, Kelle C. Freel, Catherine Schumacher, Serge Rohr, Cecile Brigand, and Georges Noel, “Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers,” Critical Reviews In Oncology Hematology, vol. 101, pp. 131–138, 2016. View at Publisher · View at Google Scholar
  • Christopher M. Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin, Raluca Ionescu-Ittu, Marjolaine Gauthier-Loiselle, Roy Nitulescu, Nicholas Sicignano, Elizabeth Butts, Eric Q. Wu, and Brian Barnett, “Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer,” Breast Cancer Research and Treatment, 2016. View at Publisher · View at Google Scholar
  • Christopher M. Gallagher, Kenneth More, Anthony Masaquel, Tripthi Kamath, Annie Guerin, Raluca Ionescu-Ittu, Roy Nitulescu, Marjolaine Gauthier-Loiselle, Nicholas Sicignano, Elizabeth Butts, Eric Q. Wu, and Brian Barnett, “Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice,” SpringerPlus, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • E. A. H. Loeffen, L. C. M. Kremer, R. L. Mulder, A. Font-Gonzalez, L. L. Dupuis, L. Sung, P. D. Robinson, M. D. van de Wetering, and W. J. E. Tissing, “The importance of evidence-based supportive care practice guidelines in childhood cancer—a plea for their development and implementation,” Supportive Care in Cancer, vol. 25, no. 4, pp. 1121–1125, 2016. View at Publisher · View at Google Scholar
  • Samir Amer, Rasha Khairy, Omnia M. Badawy, Riham Farouk, and Amira Raafat, “Fluorescence in-situ hybridization versus chromogenic in-situ hybridization in evaluating HER2 status in breast cancer by adopting tissue microarray technique,” Egyptian Journal of Pathology, vol. 37, no. 1, pp. 182–189, 2017. View at Publisher · View at Google Scholar
  • Hiba Z. Ahmed, Yuan Liu, Kelli O’Connell, Maaz Z. Ahmed, Richard J. Cassidy, Theresa, W. Gillespie, Pretesh Patel, Rathi N. Pillai, Madhusmita Behera, Conor E. Steuer, Taofeek K. Owonikoko, Suresh S. Ramalingam, Walter J. Curran, and Kristin A. Higgins, “Guideline concordant care improves overall survival for locally advanced non-small cell lung carcinoma patients: a National Cancer Data Base analysis,” Clinical Lung Cancer, 2017. View at Publisher · View at Google Scholar
  • Dirk Müller, Marion Danner, Kerstin Rhiem, Björn Stollenwerk, Christoph Engel, Linda Rasche, Lisa Borsi, Rita Schmutzler, and Stephanie Stock, “Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation,” The European Journal of Health Economics, 2017. View at Publisher · View at Google Scholar
  • Ec Inwald, O Ortmann, M Koller, F Zeman, F Hofstädter, M Evert, G Brockhoff, and M Klinkhammer-Schalke, “Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology,” Breast Cancer Research and Treatment, vol. 163, no. 1, pp. 119–130, 2017. View at Publisher · View at Google Scholar
  • Steffen Dörfel, Claus-Christoph Steffens, Dirk Meyer, Hans Tesch, Lisa Kruggel, Melanie Frank, Martina Jänicke, and Norbert Marschner, “Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study,” Breast Cancer, 2017. View at Publisher · View at Google Scholar
  • Jennifer Seelisch, Lillian Sung, Michael J. Kelly, Jennifer L. Raybin, Melissa Beauchemin, Christopher C. Dvorak, Katherine Patterson Kelly, Michael L. Nieder, Robert B. Noll, Jennifer Thackray, Nicole J. Ullrich, Sandra Cabral, L. Lee Dupuis, and Paula D. Robinson, “Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group,” Pediatric Blood & Cancer, pp. e27471, 2018. View at Publisher · View at Google Scholar
  • O. Ortmann, M. W. Beckmann, D. Wallwiener, and R. Kreienberg, “Brustkrebszentren – Modell für die Etablierung neuer Versorgungsstrukturen in der Onkologie,” Der Gynäkologe, 2018. View at Publisher · View at Google Scholar